Gardasil News and Research

RSS
Gardasil is a vaccine that prevents the types of genital human papillomavirus (HPV) that cause most cases of cervical cancer and genital warts. The vaccine, Gardasil, is given in three shots over six-months. The vaccine is routinely recommended for 11 and 12 year old girls. It is also recommended for girls and women age 13 through 26 who have not yet been vaccinated or completed the vaccine series.
Federal experts’ advice on HPV vaccine could leave adults confused

Federal experts’ advice on HPV vaccine could leave adults confused

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

Sylvester dermatologist uses HPV vaccine to treat patient with squamous cell tumors

Sylvester dermatologist uses HPV vaccine to treat patient with squamous cell tumors

HPV vaccine shows long-term safety and efficacy in protecting against most virulent strains

HPV vaccine shows long-term safety and efficacy in protecting against most virulent strains

The ratcheting cost of the pneumococcal vaccine: What gives?

The ratcheting cost of the pneumococcal vaccine: What gives?

HPV-related oropharyngeal cancer risk remains generally low, study suggests

HPV-related oropharyngeal cancer risk remains generally low, study suggests

Five important things everyone should know about cervical cancer

Five important things everyone should know about cervical cancer

Newest vaccine highly effective at preventing nine types of HPV infection, study shows

Newest vaccine highly effective at preventing nine types of HPV infection, study shows

Study finds long-term effectiveness of HPV vaccine in preventing cervical cancer

Study finds long-term effectiveness of HPV vaccine in preventing cervical cancer

HPV vaccination may be beneficial for CKD patients but not for kidney transplant recipients

HPV vaccination may be beneficial for CKD patients but not for kidney transplant recipients

European regulator concludes that evidence does not support a causal relationship between human papillomavirus vaccines and CRPS or POTS

European regulator concludes that evidence does not support a causal relationship between human papillomavirus vaccines and CRPS or POTS

UofL evaluates safety of new therapeutic vaccine in women with HPV 16, 18 infections

UofL evaluates safety of new therapeutic vaccine in women with HPV 16, 18 infections

Single dose of Cervarix vaccine effective in preventing HPV infections

Single dose of Cervarix vaccine effective in preventing HPV infections

9-Valent HPV vaccine can potentially prevent 80% of cervical cancers in the U.S.

9-Valent HPV vaccine can potentially prevent 80% of cervical cancers in the U.S.

Merck announces availability of GARDASIL 9 HPV vaccine in Canada

Merck announces availability of GARDASIL 9 HPV vaccine in Canada

Duke study proposes strategy to protect more people from HPV using limited public funds

Duke study proposes strategy to protect more people from HPV using limited public funds

International phase 2/3 trial shows Gardasil 9 vaccine protects against nine HPV types

International phase 2/3 trial shows Gardasil 9 vaccine protects against nine HPV types

New nine-valent HPV vaccine has potential to dramatically reduce cervical cancer rates

New nine-valent HPV vaccine has potential to dramatically reduce cervical cancer rates

HPV vaccine does not increase rates of STIs in adolescent females

HPV vaccine does not increase rates of STIs in adolescent females

MD Anderson president applauds FDA's approval of new vaccine for HPV-related cancers

MD Anderson president applauds FDA's approval of new vaccine for HPV-related cancers